Tesamorelin raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-07-16. Anything still debated is marked as such rather than presented as settled.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
Physicochemical behavior is dominated by the peptide backbone. The molecule is hydrophilic and carries a net positive charge near neutral pH, owing to several arginine and lysine residues. In solution it adopts a largely unstructured conformation, and aggregation is a known concern for peptide products of this size. Oxidation of methionine and deamidation of asparagine or glutamine residues are the principal chemical degradation routes. These liabilities shape how the material is formulated, handled, and analyzed, and they explain why lyophilized presentations are common in research settings.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide | GHRH analog family |
| Residue count | 44 amino acids | Matches human GHRH(1-44) backbone |
| N-terminal group | trans-3-hexenoyl | Main structural difference from native hormone |
| Appearance | White to off-white powder | Lyophilized solid form |
| Solubility class | Freely soluble in water | Peptide character; less soluble in organic solvents |
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
Signaling begins at the GHRH receptor, a class B G protein-coupled receptor displayed on somatotroph cells of the anterior pituitary. Receptor occupancy activates Gs proteins, which raise adenylyl cyclase activity and intracellular cyclic AMP, in turn driving protein kinase A dependent pathways. The downstream output is synthesis and pulsatile secretion of growth hormone into the bloodstream. Hepatic tissue and peripheral sites respond by increasing insulin-like growth factor 1 production. Somatostatin and IGF-1 itself supply negative feedback that caps the size and duration of each secretory burst.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Colyer continued his run of career best form into 2022 playing 18 games in a wing/half-forward role, and kicking multiple goals against GWS and Hawthorn, the latter of which he was arguably best on ground. Colyer signed a one-year contract extension at the end of the season. Colyer missed the first 5 games of the 2023 AFL season after a knee injury sustained during preseason saw him undergo surgery. However, he was not selected by Fremantle for the remainder of the season. Instead, he played for their WAFL affiliated side, Peel Thunder. He kicked two goals in the WAFL Grand Final against East Fremantle. In August, following the final game of Fremantle's season, Colyer along with teammate Nathan Wilson were informed that they would not be offered contracts in 2024, seemingly ending Colyer's football career after 14 years in the AFL.
, where i(θ) is the scattering function of a single particle, k = 2πn0/λ0, n0 is the refractive index of the suspending fluid, and λ0 is the vacuum wavelength of the incident light. The excess Rayleigh ratio, R(θ), is then given by
Lavín, José L; Kiil, Kristoffer; Resano, Ohiana; Ussery, David W; Oguiza, José A (2007). "Comparative genomic analysis of two-component regulatory proteins in Pseudomonas syringae". BMC Genomics. 8 397. doi:10.1186/1471-2164-8-397. PMC 2222644. PMID 17971244. Type strain of Pseudomonas syringae at BacDive – the Bacterial Diversity Metadatabase
Of the collaboration, Collins said: "Everyone knows I'm a big personality with a bold personal style to match, but I wanted to shake things up in the most unexpected way and show everyone the GC can tone down her look, without toning down her character." She added, "Neutral colours and simpler pieces are obviously worlds apart from my usual look, but I've genuinely loved seeing how I could do quiet luxury – who knew I could ever do anything "quiet" eh?" Later that month, Collins began broadcasting live on TikTok in colloboration with TikTok Shop and over the next year, engaged in live videos with various companies on the app to promote a variety of products including clothing, cosmetics, jewellery, homewares and confectionary, as well as items from her own fashion and beauty ranges. In November 2023, Collins collaborated with Dr Pepper as part of their "Try More Weird" campaign to promote "Dr Pepper Zero" in which she engaged in a social media video alongside Jedward where they pretended to dye her hair the brand's dark pink colour. Collins took part in a promotional photoshoot wearing a red wig whilst holding a can of the drink and said "Dr Pepper Zero are encouraging people to get out of their comfort zone and Try More Weird [...] So, this is me doing something that I never thought I'd do and turning my iconic blonde locks the colour of the new Dr Pepper Zero can! You guys know how much I love Dr Pepper Zero so I'm so excited to be part of this campaign and encourage you all to try something you never thought you would! Starting with an ice cold can of Dr P!".
Sources: en.wikipedia.org
In 1924, indium was found to have a valued property of stabilizing non-ferrous metals, and that became the first significant use for the element. The first large-scale application for indium was coating bearings in high-performance aircraft engines during World War II, to protect against damage and corrosion; this is no longer a major use of the element. New uses were found in fusible alloys, solders, and electronics. In the 1950s, tiny beads of indium were used for the emitters and collectors of PNP alloy-junction transistors. In the middle and late 1980s, the development of indium phosphide semiconductors and indium tin oxide thin films for liquid-crystal displays (LCD) aroused much interest. By 1992, the thin-film application had become the largest end use. Indium(III) oxide and indium tin oxide (ITO) are used as a transparent conductive coating on glass substrates in electroluminescent panels. Indium tin oxide is used as an infrared radiation filter in low-pressure sodium-vapor lamps. The infrared radiation is reflected back into the lamp, which increases the temperature within the tube and improves the performance of the lamp. Indium has many semiconductor-related applications. Some indium compounds, such as indium antimonide and indium phosphide, are semiconductors with useful properties: one precursor is usually trimethylindium (TMI), which is also used as the semiconductor dopant in II–VI compound semiconductors. InAs and InSb are used for low-temperature transistors and InP for high-temperature transistors.
In the late 2010s, graphics processing units (GPUs) that were increasingly designed with AI-specific enhancements and used with specialised TensorFlow software had replaced previously used central processing unit (CPUs) as the dominant means for large-scale (commercial and academic) machine learning models' training. Specialised programming languages such as Prolog were used in early AI research, but general-purpose programming languages like Python have become predominant. The transistor density in integrated circuits has been observed to roughly double every 18 months—a trend known as Moore's law, named after the Intel co-founder Gordon Moore, who first identified it. Improvements in GPUs have been even faster, a trend sometimes called Huang's law, named after Nvidia co-founder and CEO Jensen Huang.
from the Pliocene strata of Mininco Formation (Chile), extending known distribution of capybaras west of the Andes. Selvatici et al. (2026) determine a previously unidentified mummified animal from the Homestake Gulch site (Yukon, Canada) as a late Holocene (approximately 3000-years-old) New World porcupine, report the recovery of the first complete ancient mitochondrial genome of a member of this species, and interpret this finding as evidence of appearance of the New World porcupines in the studied area after the appearance of the boreal forest in the aftermath of the Last Glacial Period. Carrillo et al. (2026) study the evolutionary history of caviomorph rodents on the basis of data from extant and extinct members of the group, providing evidence of different trajectories of taxonomic and morphological diversification of Chinchilloidea and Octodontoidea. Evidence from the study of tooth wear of caviomorph rodents from the Paleogene strata of the Shapaja in Peruvian Amazonia, indicative of diverse dietary strategies of the studied rodents, is presented by Robinet et al. (2026). Gutstein et al. (2026) describe fossil material of a member of the genus Cardiatherium from the Bahía Inglesa Formation (Chile), providing evidence of wetter environmental conditions in the area of present-day Pacific coast of the Atacama Desert during the late Miocene. Delinschi et al. (2026) confirm the validity of Sarmatosminthus gabuniai on the basis of the analysis of fossil material from Vallesian sites in Moldova, Romania and Ukraine.
The greater sac, represented in red in the diagrams above. The lesser sac, represented in blue. The lesser sac is divided into two "omenta": The lesser omentum (or hepatogastric) is attached to the lesser curvature of the stomach and the liver. The greater omentum (or gastrocolic) hangs from the greater curvature of the stomach and loops down in front of the intestines before curving back upwards to attach to the transverse colon. In effect it is draped in front of the intestines like an apron and may serve as an insulating or protective layer. The mesentery is the part of the peritoneum through which most abdominal organs are attached to the abdominal wall and supplied with blood and lymph vessels and nerves.
Some literature even describes unique cases where muscle pain, cramping, and elevated creatine kinase levels are the only presenting symptoms instead of the classic presentation of muscle weakness.Becker muscular dystrophy occurs in approximately 1.5 to 6 in 100,000 male births, making it much less common than Duchenne muscular dystrophy. Symptoms usually appear in men at about ages 8–25, but may sometimes begin later. Genetic counseling may be advisable when potential carriers or patients want to have children. Sons of a man with Becker muscular dystrophy do not develop the disorder, but daughters will be carriers (and some carriers can experience some symptoms of muscular dystrophy), so the daughters' sons may develop the disorder.
Sources: en.wikipedia.org
No. It is a peptide that acts upstream of growth hormone release, while growth hormone is the hormone itself. The two differ in size, in receptor, and in how the body clears them.
It blocks the amino-terminal degradation step that limits native GHRH. The addition extends how long the peptide survives in plasma without removing its ability to activate the receptor.
The chain contains 44 amino acid residues. It matches the human GHRH(1-44) sequence apart from the amino-terminal modification.
The principal difference is a chemical cap on the N-terminal tyrosine that prevents rapid enzymatic cleavage. Native GHRH is degraded within minutes in plasma, whereas the modified peptide persists considerably longer. The amino acid backbone otherwise mirrors the natural hormone.